Investing in Illumina, Inc., a global leader in DNA sequencing and array-based technologies traded on the Nasdaq global select market under the ticker symbol ILMN, requires opening a brokerage account with a regulated financial platform. Once the account is funded, investors can search for the company ticker, review prevailing market prices, and execute buy orders during standard U.S. market trading hours. Prospective shareholders should evaluate the company's competitive standing in genomics, historical financial performance, research and development expenditures, and broader macroeconomic conditions influencing the life sciences sector before allocating capital.